{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:33Z","timestamp":1786986873790,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinre.2024.102430","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T22:25:10Z","timestamp":1722032710000},"page":"102430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma"],"prefix":"10.1016","volume":"48","author":[{"given":"Peng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbin","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102430_bib0001","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102430_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102430_bib0003","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinre.2024.102430_bib0004","article-title":"Cholangiocarcinoma in the Era of Immunotherapy","volume":"11","author":"Manthopoulou","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2024.102430_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.14086","article-title":"Clinical presentation, diagnosis and staging of cholangiocarcinoma","volume":"39","author":"Forner","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2024.102430_bib0006","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/bmj.322.7301.1536","article-title":"What is apoptosis, and why is it important?","volume":"322","author":"Renehan","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2024.102430_bib0007","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/liv.15392","article-title":"Bcl-x(L) as prognostic marker and potential therapeutic target in cholangiocarcinoma","volume":"42","author":"Hoffmeister-Wittmann","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2024.102430_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720979162","article-title":"Shikonin inhibits cholangiocarcinoma cell line QBC939 by regulating apoptosis, proliferation, and invasion","volume":"30","author":"Liu","year":"2021","journal-title":"Cell Transplant"},{"key":"10.1016\/j.clinre.2024.102430_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.31557\/APJCP.2023.24.2.425","article-title":"Potentiation of TRAIL-induced apoptosis in TRAIL-resistant cholangiocarcinoma cells by curcumin through the induction of DR5 membrane localization and disruption of the anti-apoptotic complex DR5\/DDX3\/GSK3beta","volume":"24","author":"Visitnonthachai","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clinre.2024.102430_bib0010","doi-asserted-by":"crossref","first-page":"14419","DOI":"10.1038\/s41598-017-14838-3","article-title":"Activation of Fas\/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells","volume":"7","author":"Carnevale","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2024.102430_bib0011","article-title":"Application of apoptosis-related genes in a multiomics-related prognostic model study of gastric cancer","volume":"13","author":"Xu","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.clinre.2024.102430_bib0012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12957-021-02175-9","article-title":"A prognostic model for hepatocellular carcinoma based on apoptosis-related genes","volume":"19","author":"Liu","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clinre.2024.102430_bib0013","article-title":"Identification and validation of an apoptosis-related gene prognostic signature for oral squamous cell carcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clinre.2024.102430_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/cco.2019.08.09","article-title":"Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy","volume":"9","author":"Turgeon","year":"2020","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.clinre.2024.102430_bib0015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41419-019-1831-7","article-title":"CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2\/BCL-XL inhibitor ABT-263","volume":"10","author":"Huang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clinre.2024.102430_bib0016","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/hep.24698","article-title":"miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma","volume":"55","author":"Razumilava","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102430_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0888-7543(05)80276-9","article-title":"The CCAAT\/enhancer binding protein (C\/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C\/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1","volume":"14","author":"Hendricks-Taylor","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.clinre.2024.102430_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2091615","article-title":"Cebpb regulates skeletal stem cell osteogenic differentiation and fracture healing via the WNT\/beta-catenin pathway","volume":"2022","author":"Wang","year":"2022","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.clinre.2024.102430_bib0019","article-title":"E3 ubiquitin ligase COP1-mediated CEBPB ubiquitination regulates the inflammatory response of macrophages in sepsis-induced myocardial injury","author":"Yu","year":"2023","journal-title":"Mamm Genome"},{"key":"10.1016\/j.clinre.2024.102430_bib0020","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/hmg\/ddad022","article-title":"CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation","volume":"32","author":"Qi","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinre.2024.102430_bib0021","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/cdd.2008.185","article-title":"The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death","volume":"16","author":"Burton","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clinre.2024.102430_bib0022","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.7314\/APJCP.2014.15.14.5873","article-title":"High expression of HIF-1alpha, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis","volume":"15","author":"Thongchot","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clinre.2024.102430_bib0023","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.clinre.2024.102430_bib0024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygeno.2021.12.008","article-title":"Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatich cholangiocarcinoma","volume":"114","author":"He","year":"2022","journal-title":"Genomics"},{"key":"10.1016\/j.clinre.2024.102430_bib0025","doi-asserted-by":"crossref","first-page":"G213","DOI":"10.1152\/ajpgi.00243.2022","article-title":"DAGLbeta is the principal synthesizing enzyme of 2-AG and promotes aggressive phenotype of intrahepatic cholangiocarcinoma via AP-1\/DAGLbeta\/miR4516 feedforward circuitry","volume":"325","author":"Ma","year":"2023","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clinre.2024.102430_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2024.102430_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103398","article-title":"IL-1alpha and colorectal cancer pathogenesis: enthralling candidate for anti-cancer therapy","volume":"163","author":"Cheng","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clinre.2024.102430_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-38315-2_1","article-title":"IL-1 Signaling in Tumor Microenvironment","volume":"1240","author":"Zhang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clinre.2024.102430_bib0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clinre.2024.102430_bib0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.hpb.2021.11.008","article-title":"Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma","volume":"24","author":"Yamada","year":"2022","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.clinre.2024.102430_bib0031","doi-asserted-by":"crossref","first-page":"e1773","DOI":"10.1002\/cnr2.1773","article-title":"MAP3K1 rs889312 polymorphism and cancer prognosis: a systematic review and meta-analysis","volume":"6","author":"Aziz","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.clinre.2024.102430_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154200","article-title":"Desmoglein 3 (Dsg3) expression in cancer: a tissue microarray study on 15,869 tumors","volume":"240","author":"Viehweger","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.clinre.2024.102430_bib0033","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.onc.1209802","article-title":"DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis","volume":"26","author":"Chen","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.clinre.2024.102430_bib0034","doi-asserted-by":"crossref","first-page":"e64088","DOI":"10.1371\/journal.pone.0064088","article-title":"DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF\/LEF-Myc\/cyclin D1\/MMP signaling pathway","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinre.2024.102430_bib0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood.V85.3.650.bloodjournal853650","article-title":"A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells","volume":"85","author":"Tse","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.clinre.2024.102430_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6282654","article-title":"MLLT11 siRNA inhibits the migration and promotes the apoptosis of MDA-MB-231 breast cancer cells","volume":"2023","author":"Liu","year":"2023","journal-title":"Breast J"},{"key":"10.1016\/j.clinre.2024.102430_bib0037","first-page":"746","article-title":"[A uNick protein]","volume":"27","author":"Labelle-Cote","year":"2011","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.clinre.2024.102430_bib0038","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/1471-2407-11-443","article-title":"Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo","volume":"11","author":"Labelle-Cote","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinre.2024.102430_bib0039","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","article-title":"Metabolic reprogramming in cholangiocarcinoma","volume":"77","author":"Raggi","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102430_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.696961","article-title":"Targeting fatty acid synthase modulates metabolic pathways and inhibits cholangiocarcinoma cell progression","volume":"12","author":"Tomacha","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinre.2024.102430_bib0041","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10555-018-9733-1","article-title":"Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents","volume":"37","author":"Erazo-Oliveras","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.clinre.2024.102430_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1024423","article-title":"The cAMP-signaling cancers: clinically-divergent disorders with a common central pathway","volume":"13","author":"Bolger","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clinre.2024.102430_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071692","article-title":"Cyclic AMP signaling in biliary proliferation: a possible target for cholangiocarcinoma treatment?","volume":"10","author":"Baiocchi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clinre.2024.102430_bib0044","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15403\/jgld-4634","article-title":"Bile composition - which components can have clinical significance? A review of the literature","volume":"32","author":"Podgorski","year":"2023","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.clinre.2024.102430_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117235","article-title":"Identification and validation of volatile organic compounds in bile for differential diagnosis of perihilar cholangiocarcinoma","volume":"541","author":"Gui","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinre.2024.102430_bib0046","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.clinre.2024.102430_bib0047","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12935-020-01676-z","article-title":"Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection","volume":"20","author":"Hu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.clinre.2024.102430_bib0048","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clinre.2024.102430_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103375","article-title":"Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target","volume":"67","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clinre.2024.102430_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41389-022-00398-3","article-title":"Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy","volume":"11","author":"Raskov","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.clinre.2024.102430_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236131","article-title":"Neutrophil extracellular traps (NETs) in cancer metastasis","volume":"13","author":"Kaltenmeier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinre.2024.102430_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010213","article-title":"Rigosertib and cholangiocarcinoma: a cell cycle affair","volume":"23","author":"Malacrida","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.clinre.2024.102430_bib0053","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1349-7006.1999.tb00688.x","article-title":"Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor","volume":"90","author":"Tanaka","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.clinre.2024.102430_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109349","article-title":"AMG900 as novel inhibitor of the translationally controlled tumor protein","volume":"334","author":"Fischer","year":"2021","journal-title":"Chem Biol Interact"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T03:52:54Z","timestamp":1727754774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2210740124001517"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102430","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102430"}}